Jorne Lionel Biccler

COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study

Allison Barraclough, Musa Alzahrani, Marianne Schmidt Ettrup et al. · Blood Advances · 2019 · 51 citations · Full text

Simplicity at the cost of predictive accuracy in diffuse large B‐cell lymphoma: a critical assessment of the R‐<scp>IPI</scp>,<scp>IPI</scp>, and<scp>NCCN</scp>‐<scp>IPI</scp>

Jorne Lionel Biccler, Sandra Eloranta, Peter de Nully Brown et al. · Cancer Medicine · 2017 · 38 citations · Full text

Prognosis, Immunology, Pathology +19

Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group Study

Jorne Lionel Biccler, Sandra Eloranta, Peter de Nully Brown et al. · JCO Clinical Cancer Informatics · 2018 · 37 citations

Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study

Jorne Lionel Biccler, Ingrid Glimelius, Sandra Eloranta et al. · Journal of Clinical Oncology · 2019 · 36 citations · Full text

Risk of death, relapse or progression, and loss of life expectancy at different progression-free survival milestones in primary central nervous system lymphoma

Jorne Lionel Biccler, Kerry J. Savage, Peter de Nully Brown et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2019 · 19 citations